April 9, 2012 — Elekta announced it has received clearance to CE mark Agility, a beam-shaping device integrated into the head of a linear accelerator (linac). Patients and clinics will benefit from the speed and reliability of this new MLC (multileaf collimator) design.

April 6, 2012 — Positron Corp. announced the approval of its Nuclear Regulatory Commission (NRC) manufacturing and distribution license amendment for the company's radiopharmaceutical manufacturing facility in Crown Point, Ind.

April 5, 2012 — The American College of Cardiology (ACC) released a list of “Five Things Physicians and Patients Should Question” in cardiology as part of Choosing Wisely, an initiative of the ABIM Foundation. The list identifies five targeted, evidence-based recommendations that can support physicians in working with their patients to make wise choices about their care.

April 5, 2012 - SK Capital Partners, a U.S. based private investment firm, and IBA (Ion Beam Applications S.A.) announced that they have closed on their previously announced agreement to create IBA Molecular, a jointly-owned company derived from IBA’s worldwide radiopharmaceutical division. IBA Molecular is a worldwide leader in the manufacturing and distribution of radioactive isotopes used for medical imaging and therapy, with over 50 locations in the United States, Europe and Asia and employs over 1,000 people. The transaction is valued at approximately €180 million ($239 million). SK Capital will own 60 percent of the recapitalized entity and IBA will retain a 40 percent stake.

New guidelines for CT-guided biopsies of lung nodules significantly reduce radiation exposure, allowing individuals the benefit of the procedure, which may cut down on overall lung cancer deaths. This research was presented at the Society of Interventional Radiology's (SIR) 37th Annual Scientific Meeting in San Francisco.